SOURCE: bioRASI

November 09, 2007 10:14 ET

bioRASI to Introduce the New Translational Clinical Development Methodology at AAPS in San Diego

The Translational Clinical Development CRO Creates New Infrastructure to Optimize Innovative Therapeutics, Generics, and 505(b)(2) Programs

HOLLYWOOD, FL--(Marketwire - November 9, 2007) - bioRASI announced today that it will participate in the 2007 AAPS Annual Meeting and Exhibition in San Diego, CA on November 11-15th. It will be exhibiting at booth #2908 and will unveil its new management methodology that optimizes Innovative Therapeutics, Generics and 505(b)(2) Programs.

"We are excited that bioRASI's Program Management Services Branch is continually developing innovative strategies and methodologies for optimizing the translational clinical development programs of our sponsors," said bioRASI's chairman, Dr. Boris Reznik. "Our unique systems methodology helps our sponsors to save critical amounts of time and to achieve unprecedented success rates in taking their early candidates through clinical proof."

bioRASI's Program Management Services Branch uses the new integrative management system infrastructure, known as BPI 2008, to successfully manage and optimize the outcome of the key translational steps, including discovery, IND enablement, and early clinical phase studies.

Through its Innovative and Generics divisions, bioRASI leverages its in-depth knowledge and global resources to provide a full range of services to its sponsors, including Program Management, Regulatory, Clinical, Data Management & Analysis, and Compliance & Audit.

About bioRASI

bioRASI, the translational clinical development CRO, is focused on managing and optimizing the progression of lab candidates through clinical proof. bioRASI's Innovative Division helps companies bring their candidate from IND enablement through Phase II clinical proof studies as its Generics Division focuses on the translation of the candidate through pilot and pivotal clinical studies. bioRASI leverages its full service capabilities and global resources to achieve unparalleled scientific, clinical and business results for its sponsors. bioRASI is headquartered in Hollywood, FL and has regional offices, labs, and clinics across the globe.

Contact Information